The Medicines (Pharmacies) (Applications for Registration and Fees) Amendment Regulations 2006
In accordance with section 129(6) of that Act, they have consulted such organisations as appear to them to be representative of interests likely to be affected by the Regulations.
Citation and commencement1.
These Regulations may be cited as the Medicines (Pharmacies) (Applications for Registration and Fees) Amendment Regulations 2006 and shall come into force on 1st January 2007.
Amendment of the Medicines (Pharmacies) (Applications for Registration and Fees) Regulations 19732.
(a)
in paragraph (1) (fee for registration of premises), for “£474” substitute “£492” and for “£93” (fee where premises are in Northern Ireland) substitute “£97”;
(b)
in paragraph (2) (retention fee), for “£150” substitute “£156” and for “£130” (fee where premises are in Northern Ireland) substitute “£135”; and
(c)
in paragraph (3) (additional sum by way of penalty), for “£474” substitute “£492” and for “£270” (sum where premises are in Northern Ireland) substitute “£281”.
Revocation3.
Signed by authority of the Secretary of State for Health
Sealed with the Official Seal of the Department of Health, Social Services and Public Safety
These Regulations further amend the Medicines (Pharmacies) (Applications for Registration and Fees) Regulations 1973 (“the principal Regulations”) as follows—
regulation 2(a) increases the fees for registration of premises at which a retail pharmacy business is, or is to be, carried on from £474 to £492 (where the premises are in Great Britain) and from £93 to £97 (where the premises are in Northern Ireland);
regulation 2(b) increases subsequent annual fees (retention fees) from £150 to £156 (where the premises are in Great Britain) and from £130 to £135 (where the premises are in Northern Ireland);
regulation 2(c) increases the penalty for failure to pay retention fees (payable in circumstances specified in section 76(2) of the Medicines Act 1968) from £474 to £492 (where premises are in Great Britain) and from £270 to £281 (where the premises are in Northern Ireland).
These Regulations also revoke the Medicines (Pharmacies) (Applications for Registration and Fees) Amendment Regulations 2005, which increased the fees in the principal Regulations, the effect of which is spent.
A full Regulatory Impact Assessment of the effect that this instrument will have on the costs of business is available from the Department of Health, Pharmacy and Prescription Branch, Room 520, Eileen House, 80-90 Newington Causeway, London SE1 6EE. Copies have been placed in the libraries of both Houses of Parliament.